Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-02

Clinical Trial Update: Terazosin Effect on Cardiac Changes in Early Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether terazosin affects cardiac changes in early Parkinson's disease. The study includes participants with REM Sleep Behavio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Terazosin (terazosin)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: REM Sleep Behavior Disorder, Pre-motor Parkinson's Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING